Prof Annette Byrne (co-ordinator) and colleagues were awarded c. €6million for the European Commission (EC) funded H2020 Health industry/academia project ‘COLOSSUS’ focused on the development of new biomarkers and therapies for difficult to treat metastatic colorectal cancer. COLOSSUS was ranked #1 from 206 applications submitted to H2020 Call PM-02-2017 from across Europe.
more information can be found below.